InMed Pharmaceuticals Inc. (INM)
USD 4.35
(-14.71%)
USD 4.35
(-14.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.98 Million | -7.28 Million | -15.58 Million | -9.79 Million | -7.15 Million | -6.67 Million |
| Net Income | -7.67 Million | -7.94 Million | -18.6 Million | -10.2 Million | -8.68 Million | -10.09 Million |
| Depreciation & Amortization | 604.51 Thousand | 595.99 Thousand | 511.78 Thousand | 120.86 Thousand | 161.96 Thousand | 94.71 Thousand |
| Deferred income taxes | - | 356.89 Thousand | - | -242.38 Thousand | 80.85 Thousand | 1.92 |
| Stock-based compensation | 137.71 Thousand | 278.15 Thousand | 697.89 Thousand | 610.19 Thousand | 994.4 Thousand | 3.11 Million |
| Change in working capital | -369.33 Thousand | -565.82 Thousand | -2.73 Million | -450.45 Thousand | 351.3 Thousand | 283.89 Thousand |
| Other non-cash items | 316.82 Thousand | -803.00 | 4.45 Million | 374.22 Thousand | 18.61 Thousand | -71.39 Thousand |
| Investing Cash Flow | -9293.00 | -661.8 Thousand | -672.99 Thousand | -1725.00 | 3.61 Million | -2.1 Million |
| Investments in PPE | -9293.00 | -161.8 Thousand | -39.1 Thousand | -1725.00 | -41.85 Thousand | -27.03 Thousand |
| Acquisitions | - | -500 Thousand | -208.89 Thousand | - | 541.00 | - |
| Investment purchases | -42.08 Thousand | -42.26 Thousand | -425 Thousand | - | -42.09 Thousand | -2.06 Million |
| Sales/Maturities of investments | 42.08 Thousand | 42.26 Thousand | 425 Thousand | - | 3.7 Million | - |
| Other Investing Activities | -9000.00 | -501.79 Thousand | -425 Thousand | - | -9.01 | -17.02 Thousand |
| Financing Cash Flow | 4.65 Million | 10.68 Million | 15.07 Million | 10.85 Million | -42.07 Thousand | 272.5 Thousand |
| Debt repayment | - | - | -290.82 Thousand | - | -71.29 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.65 Million | 12 Million | 17.14 Million | 12.47 Million | -30.99 Thousand | 205.87 Thousand |
| Other Financing Activities | 175.00 | -1.31 Million | -1.78 Million | -1.61 Million | -42.07 Thousand | 272.5 Thousand |
| Accounts receivables | -92.43 Thousand | -219.14 Thousand | -40 Thousand | 40.19 Thousand | 16.98 Thousand | -24.08 Thousand |
| Accounts payables | 45.28 Thousand | -928.4 Thousand | - | - | - | - |
| Inventory | 66.22 Thousand | 565.56 Thousand | -2 Million | - | - | - |
| Other working capital | -343.11 Thousand | 16.17 Thousand | -687.51 Thousand | -490.64 Thousand | 334.32 Thousand | 307.97 Thousand |
| Cash at beginning of period | 8.91 Million | 6.17 Million | 7.36 Million | 5.8 Million | 9.42 Million | 18.38 Million |
| Cash at end of period | 6.57 Million | 8.91 Million | 6.17 Million | 7.36 Million | 5.79 Million | 9.8 Million |
| Capital Expenditure | -9293.00 | -161.8 Thousand | -39.1 Thousand | -1725.00 | -41.85 Thousand | -27.03 Thousand |
| Effect of forex changes on cash | - | -651.00 | - | 494.96 Thousand | -565.23 Thousand | 0.60 |
| Net cash flow / Change in cash | -2.34 Million | 2.73 Million | -1.18 Million | 1.55 Million | -3.63 Million | -8.57 Million |
| Free Cash Flow | -6.99 Million | -7.44 Million | -15.62 Million | -9.79 Million | -7.19 Million | -6.7 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.93 Million | -1.72 Million | -1.47 Million | -2.53 Million | -7.94 Million | -338.39 Thousand |
| Depreciation & Amortization | 151.86 Thousand | 150.38 Thousand | 152.6 Thousand | 149.36 Thousand | 595.99 Thousand | 150.97 Thousand |
| Deferred income taxes | -264.38 Thousand | - | 169.43 Thousand | 94.94 Thousand | 356.89 Thousand | 7.63 Million |
| Stock-based compensation | 38.95 Thousand | 55.3 Thousand | 18.26 Thousand | 25.19 Thousand | 278.15 Thousand | 40.48 Thousand |
| Change in working capital | 665.6 Thousand | -423.34 Thousand | -709.77 Thousand | 93.65 Thousand | -565.82 Thousand | -263.48 Thousand |
| Other non-cash items | 52.08 Thousand | 719.47 Thousand | -481.00 | -538.00 | -803.00 | -7.88 Million |
| Investing Cash Flow | 362.46 | -71.46 | -9291.00 | - | -661.8 Thousand | -33.6 Thousand |
| Investments in PPE | 9291.13 | -71.46 | -9219.67 | - | -161.8 Thousand | -33.6 Thousand |
| Acquisitions | - | - | - | - | -500 Thousand | -118.45 Thousand |
| Investment purchases | 431.00 | -21.35 Thousand | 163.66 | -21.31 Thousand | -42.26 Thousand | -42.15 Thousand |
| Sales/Maturities of investments | -431.00 | 21.35 Thousand | -163.66 | 21.31 Thousand | 42.26 Thousand | 42.15 Thousand |
| Other Investing Activities | -8928.67 | - | -71.33 | - | -501.79 Thousand | 118.45 Thousand |
| Financing Cash Flow | 176.00 | 34.79 Thousand | 4.65 Million | - | 10.68 Million | -654.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.00 | 34.79 Thousand | 4.65 Million | - | 12 Million | -12 Million |
| Other Financing Activities | 175.00 | - | 6.16 Million | - | -1.31 Million | 11.99 Million |
| Accounts receivables | -145.15 Thousand | 164.31 Thousand | -207.01 Thousand | 94.54 Thousand | -219.14 Thousand | -111.79 Thousand |
| Accounts payables | 1.23 Million | -106.71 Thousand | -749.19 Thousand | -375.05 Thousand | -928.4 Thousand | -912.23 Thousand |
| Inventory | -92.78 Thousand | -444.47 Thousand | 217.78 Thousand | 390.32 Thousand | 565.56 Thousand | -18.59 Thousand |
| Other working capital | 903.54 Thousand | -36.46 Thousand | 28.65 Thousand | -16.17 Thousand | 16.17 Thousand | 779.13 Thousand |
| Cash at beginning of period | 7.6 Million | 9.53 Million | 6.73 Million | 8.91 Million | 6.17 Million | 9.6 Million |
| Cash at end of period | 6.57 Million | 7.6 Million | 9.53 Million | 6.73 Million | 8.91 Million | 8.91 Million |
| Capital Expenditure | 9291.13 | -71.46 | -9219.67 | - | -161.8 Thousand | -33.6 Thousand |
| Effect of forex changes on cash | 412.96 Million | - | -412.96 Million | - | -651.00 | 3.00 |
| Net cash flow / Change in cash | -1.02 Million | -1.93 Million | 2.79 Million | -2.17 Million | 2.73 Million | -691.54 Thousand |
| Free Cash Flow | -1.01 Million | -1.96 Million | -1.85 Million | -2.17 Million | -7.44 Million | -691.54 Thousand |
AMZ
8038
KHNZ
ALCLS
DRNG
MTRE3